Asia Pacific Non-opioid Pain Treatment Market Size & Outlook
Related Markets
Asia Pacific non-opioid pain treatment market highlights
- The Asia Pacific non-opioid pain treatment market generated a revenue of USD 9,046.5 million in 2024.
- The market is expected to grow at a CAGR of 9.3% from 2025 to 2030.
- In terms of segment, nsaids was the largest revenue generating drug class in 2024.
- Local Anesthetics is the most lucrative drug class segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 9,046.5 million |
| Market revenue in 2030 | USD 15,327.5 million |
| Growth rate | 9.3% (CAGR from 2025 to 2030) |
| Largest segment | Nsaids |
| Fastest growing segment | Local Anesthetics |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | NSAIDs, Acetaminophen, Local Anesthetics |
| Key market players worldwide | Novartis AG ADR, Teva Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, GSK PLC ADR, Pfizer Inc, Perrigo Co PLC, LNK International Inc., Cipla Ltd DR, Johnson & Johnson, Pacira BioSciences Inc, Pierrel S.p.A |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.0% of the global non-opioid pain treatment market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 15,327.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non-opioid Pain Treatment Market Scope
Non-opioid Pain Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Pierrel S.p.A | View profile | 501-1000 | Capua, Campania, Italy, Europe | http://www.pierrelgroup.com |
| LNK International Inc. | View profile | 1001-5000 | Hauppauge, New York, United States, North America | http://linkintl.com |
| Pacira BioSciences Inc | View profile | 712 | 5401 West Kennedy Boulevard, Suite 890, Tampa, FL, United States, 33609 | https://www.pacira.com |
| Perrigo Co PLC | View profile | 9140 | The Sharp Building, Hogan Place, Dublin, Ireland, D02 TY74 | https://www.perrigo.com |
| Dr. Reddy’s Laboratories | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | http://www.drreddys.com/ |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| GSK PLC ADR | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Asia Pacific non-opioid pain treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-opioid pain treatment market will help companies and investors design strategic landscapes.
Nsaids was the largest segment with a revenue share of 58.91% in 2024. Horizon Databook has segmented the Asia Pacific non-opioid pain treatment market based on nsaids, acetaminophen, local anesthetics covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Asia Pacific non-opioid pain treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific non-opioid pain treatment market databook
-
Our clientele includes a mix of non-opioid pain treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific non-opioid pain treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific non-opioid pain treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific non opioid pain treatment market report size, by country, 2018-2030 (US$M)
Asia Pacific Non-opioid Pain Treatment Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
